Arch Biopartners Inc.   Report issue

For profit Phase 2
Founded: Toronto Canada (2010)

Organization Overview

First Clinical Trial
2019
NCT03772678
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Arch Biopartners Inc.